Forum Topic Diabetes
  • Conversation: Real world data back Sanofi’s Toujeo for type I diabetes

    • March 20, 2018 3:36 PM GMT
      • Post(s)
        548

      Real world data back Sanofi’s Toujeo for type I diabetes

      Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients with type I diabetes.
      The data, presented for the first time at ENDO 2018, the Endocrine Society’s 100th Annual Meeting & Expo, in Chicago, showed that the drug is linked with statistically significant improvements in HbA1c in patients with the condition, with a mean difference of from baseline to month six of –4.4 mmol/mol.
      The study also showed no change in the number of patients reporting either diabetic ketoacidosis (DKA) or severe hypoglycaemia after starting treatment with Toujeo (Gla-300).
      Read more: http://www.pharmatimes.com/news/real_world_data_back_sanofis_toujeo_for_type_i_diabetes_1228401

Add Reputation

Do you want to add reputation for this member by this post?

or cancel